UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study

Liver international, 2015-09, Vol.35 (9), p.2155-2166

2015

Volltextzugriff (PDF)

Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis

Liver international, 2016-09, Vol.36 (9), p.1239-1251

2016

Volltextzugriff (PDF)

A meta‐analysis of single HCV‐untreated arm of studies evaluating outcomes after curative treatments of HCV‐related hepatocellular carcinoma

Liver international, 2017-08, Vol.37 (8), p.1157-1166

2017

Volltextzugriff (PDF)

Delisting HCV‐infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting

Liver international, 2018-12, Vol.38 (12), p.2170-2177

2018

Volltextzugriff (PDF)

Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma

Liver international, 2015-10, Vol.35 (10), p.2311-2317

2015

Volltextzugriff (PDF)

Follow‐up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin‐free treatment

Liver international, 2018-06, Vol.38 (6), p.1028-1035

2018

Volltextzugriff (PDF)

Non‐invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low‐level viremia

Liver international, 2018-01, Vol.38 (1), p.68-75

2018

Volltextzugriff (PDF)

Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma

Liver international, 2024-07, Vol.44 (7), p.1588-1599

2024

Volltextzugriff (PDF)

Combining albumin‐bilirubin score with future liver remnant predicts post‐hepatectomy liver failure in HBV‐associated HCC patients

Liver international, 2018-03, Vol.38 (3), p.494-502

2018

Volltextzugriff (PDF)

The impact of HCV eradication by direct‐acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study

Liver international, 2019-03, Vol.39 (3), p.448-454

2019

Volltextzugriff (PDF)

Direct‐acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C

Liver international, 2017-08, Vol.37 (8), p.1122-1127

2017

Volltextzugriff (PDF)

The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure

Liver international, 2015-03, Vol.35 (3), p.999-1009

2015

Volltextzugriff (PDF)

Liver-infiltrating CD8+ lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma

Liver international, 2016-03, Vol.36 (3), p.434-444

2016

Volltextzugriff (PDF)

Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus‐related cirrhosis who attained sustained virological response

Liver international, 2017-10, Vol.37 (10), p.1526-1534

2017

Volltextzugriff (PDF)

Serum microRNA profiles as diagnostic biomarkers for HBV‐positive hepatocellular carcinoma

Liver international, 2017-06, Vol.37 (6), p.888-896

2017

Volltextzugriff (PDF)

Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis

Liver international, 2012-02, Vol.32 (2), p.231-240

2012

Volltextzugriff (PDF)

Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?

Liver international, 2018-12, Vol.38 (12), p.2108-2116

2018

Volltextzugriff (PDF)

Validation of PAGE‐B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir

Liver international, 2017-12, Vol.37 (12), p.1788-1795

2017

Volltextzugriff (PDF)

On‐treatment changes of liver stiffness at week 26 could predict 2‐year clinical outcomes in HBV‐related compensated cirrhosis

Liver international, 2018-06, Vol.38 (6), p.1045-1054

2018

Volltextzugriff (PDF)

Natural history of chronic hepatitis B: what exactly has REVEAL Revealed?

Liver international, 2012-10, Vol.32 (9), p.1333-1341

2012

Volltextzugriff (PDF)

Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma

Liver international, 2013-04, Vol.33 (4), p.595-604

2013

Volltextzugriff (PDF)

A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib

Liver international, 2015-09, Vol.35 (9), p.2147-2154

2015

Volltextzugriff (PDF)

Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma

Liver international, 2016-04, Vol.36 (4), p.580-587

2016

Volltextzugriff (PDF)

Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma

Liver international, 2015-07, Vol.35 (7), p.1786-1800

2015

Volltextzugriff (PDF)

Clinical outcomes and management of patients with chronic hepatitis B and liver stiffness measurement in the grey zone

Liver international, 2019-03, Vol.39 (3), p.494-502

2019

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Aktive Filter

SpracheSpanisch

Zeitschrift / SerieLiver International

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(125)

Publikationsform

Artikel
(125)

Sprache

Englisch
(125)

Erscheinungsjahr

n.n

Thema

Humans
(123)
Gastroenterology & Hepatology
(120)
Life Sciences & Biomedicine
(120)
Science & Technology
(120)
Carcinoma, Hepatocellular - Virology
(93)
Hepatocellular Carcinoma
(92)
Liver Neoplasms - Virology
(90)
Female
(88)
Male
(86)
Middle Aged
(82)
Adult
(60)
Aged
(57)
Antiviral Agents - Therapeutic Use
(47)
Liver Cirrhosis - Virology
(46)
Hepatitis B Virus
(37)
Risk Factors
(37)
Cirrhosis
(36)
Hepatitis
(34)
Retrospective Studies
(32)
Hepatitis C Virus
(31)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Liver
(1)
Liver Int
(1)

Menü

Weitere Dienste

Einstellungen

Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study

Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis

A meta‐analysis of single HCV‐untreated arm of studies evaluating outcomes after curative treatments of HCV‐related hepatocellular carcinoma

Delisting HCV‐infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting

Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma

Follow‐up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin‐free treatment

Non‐invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low‐level viremia

Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma

Combining albumin‐bilirubin score with future liver remnant predicts post‐hepatectomy liver failure in HBV‐associated HCC patients

The impact of HCV eradication by direct‐acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study

Direct‐acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C

The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure

Liver-infiltrating CD8+ lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma

Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus‐related cirrhosis who attained sustained virological response

Serum microRNA profiles as diagnostic biomarkers for HBV‐positive hepatocellular carcinoma

Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis

Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?

Validation of PAGE‐B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir

On‐treatment changes of liver stiffness at week 26 could predict 2‐year clinical outcomes in HBV‐related compensated cirrhosis

Natural history of chronic hepatitis B: what exactly has REVEAL Revealed?

Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma

A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib

Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma

Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma

Clinical outcomes and management of patients with chronic hepatitis B and liver stiffness measurement in the grey zone

Aktive Filter

Suchergebnisse filtern